v3.24.2.u1
CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
9 Months Ended
Jun. 30, 2024
Jun. 30, 2023
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss $ (12,947,748) $ (12,352,988)
Adjustments to reconcile net loss to net cash (used in) operating activities    
Depreciation and amortization 59,009 259,541
Stock based compensation - stock option grants 2,331,516 2,464,045
Issuance of common stock for services 277,010 0
Loss on disposal of assets 0 384,137
Amortization of operating lease right-of-use asset 162,647 96,161
Amortization of debt issuance costs 375,859 0
Interest expense for extension of notes and warrants 594,761 349,721
Changes in operating assets and liabilities:    
Other long-term assets (143,478) (1,999)
Operating lease right-of-use liability (150,329) (99,803)
Accounts payable - trade and accrued expenses (133,011) (74,866)
NET CASH (USED IN) OPERATING ACTIVITIES (9,573,764) (8,976,051)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Purchase of research and development equipment (66,352) (80,798)
NET CASH (USED IN) INVESTING ACTIVITIES: (66,352) (80,798)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Proceeds from debt offering 3,805,699 0
Proceeds from issuance of common stock offering, net 203,105 0
Payments for debt offering (262,450) 0
Proceeds from issuance of common stock for stock options exercise 0 4,687
Proceeds from issuance of common stock for warrant exercise 0 387,335
NET CASH PROVIDED BY FINANCING ACTIVITIES 3,746,354 392,022
NET (DECREASE) IN CASH AND CASH EQUIVALENTS (5,893,762) (8,664,827)
CASH AND CASH EQUIVALENTS, beginning of period 8,023,716 12,593,692
CASH AND CASH EQUIVALENTS, end of period 2,129,954 3,928,865
Supplemental disclosure of non-cash financing activity:    
Deemed dividends on Series C and D Preferred Stock 262,283 3,337,494
Common stock dividends on Series D Preferred Stock 0 1,627,230
Warrants issued for debt offering 1,536,743 0
Common stock issued for debt payment $ 240,000 $ 0

Source